Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15183 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Fatima Aldrea und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Damascus Hospital, Damascus, Syria. Hauptthemen laut MEDLINE: Methotrexate, Macrophage Activation Syndrome, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Methotrexate, prescribed for Still's disease, may elevate MAS susceptibility.Exercise caution in its usage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Damascus Hospital, Damascus, Syria.
- Department of Family Medicine, Damascus Hospital, Damascus, Syria.
- Department of Rheumatology, Damascus Hospital, Damascus, Syria.
ORCID-Profile: Fatima Aldrea, Mohamad Klib, Suzan Jalal, Aisha Najak, Widad Aji
Zitieren
APA
Aldrea, F., Klib, M., Jalal, S., Najak, A., & Aji, W. (2024). Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15183
Vancouver
Aldrea F, Klib M, Jalal S, Najak A, Aji W. Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15183
BibTeX
@article{Aldrea2024,
author = {Aldrea, Fatima and Klib, Mohamad and Jalal, Suzan and Najak, Aisha and Aji, Widad},
title = {Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15183}
}
EUVIMED